{"component": "definition", "props": {"groups": [{"snippet": "means a Phase \u2587 \u2587\u2587\u2587\u2587\u2587, \u2587\u2587\u2587\u2587\u2587 \u2587 \u2587\u2587\u2587\u2587\u2587, \u2587\u2587\u2587\u2587\u2587 \u2587 Trial or Phase 4 Trial, or such other study in humans that is conducted in accordance with good clinical practices and is designed to generate data in support or maintenance of an NDA, MAA or other similar marketing application.", "snippet_links": [{"key": "phase-\u2587", "type": "clause", "offset": [8, 15]}, {"key": "phase-4-trial", "type": "definition", "offset": [55, 68]}, {"key": "other-study", "type": "clause", "offset": [78, 89]}, {"key": "in-accordance-with", "type": "definition", "offset": [118, 136]}, {"key": "good-clinical-practices", "type": "definition", "offset": [137, 160]}, {"key": "to-generate", "type": "definition", "offset": [177, 188]}, {"key": "maintenance-of", "type": "clause", "offset": [208, 222]}, {"key": "marketing-application", "type": "definition", "offset": [252, 273]}], "samples": [{"hash": "7CoFyFfYwto", "uri": "/contracts/7CoFyFfYwto#clinical-studies", "label": "Neurology Drug Discovery and Development Collaboration, Option and License Agreement (Ionis Pharmaceuticals Inc)", "score": 32.8384666443, "published": true}, {"hash": "5QQ8kSgUDvm", "uri": "/contracts/5QQ8kSgUDvm#clinical-studies", "label": "Strategic Neurology Drug Discovery and Development Collaboration, Option and License Agreement (Ionis Pharmaceuticals Inc)", "score": 30.1608486176, "published": true}, {"hash": "3al7Tnjde0R", "uri": "/contracts/3al7Tnjde0R#clinical-studies", "label": "Research Collaboration, Option and License Agreement (Ionis Pharmaceuticals Inc)", "score": 29.1587944031, "published": true}], "size": 24, "hash": "48c3ef852e47f56f647a0eb97317ebe0", "id": 1}, {"snippet": "means any clinical studies of a Licensed Product conducted on humans.", "snippet_links": [{"key": "licensed-product", "type": "clause", "offset": [32, 48]}], "samples": [{"hash": "p4S3OaUU78", "uri": "/contracts/p4S3OaUU78#clinical-studies", "label": "License Agreement (Athenex, Inc.)", "score": 31.3463382721, "published": true}, {"hash": "dSNc37CPaTV", "uri": "/contracts/dSNc37CPaTV#clinical-studies", "label": "License Agreement (Athenex, Inc.)", "score": 31.3463382721, "published": true}, {"hash": "cMLx2pnMSkx", "uri": "/contracts/cMLx2pnMSkx#clinical-studies", "label": "License Agreement (Athenex, Inc.)", "score": 29.4982891083, "published": true}], "size": 22, "hash": "b8676b0929bf3730ef22894ff3230ef6", "id": 2}, {"snippet": "means \u2587\u2587\u2587\u2587\u2587 \u2587, \u2587\u2587\u2587\u2587\u2587 \u2587, \u2587\u2587\u2587\u2587\u2587 \u2587, \u2587\u2587\u2587\u2587\u2587 3, and such other tests and studies in human subjects that are required by Applicable Law, or otherwise recommended by the Regulatory Authorities, to obtain or maintain Regulatory Approvals for a Licensed Product for one (1) or more indications, including tests or studies that are intended to expand the Product Labeling for such Licensed Product with respect to such indication.", "snippet_links": [{"key": "tests-and-studies", "type": "clause", "offset": [57, 74]}, {"key": "in-human-subjects", "type": "clause", "offset": [75, 92]}, {"key": "required-by", "type": "definition", "offset": [102, 113]}, {"key": "applicable-law", "type": "definition", "offset": [114, 128]}, {"key": "regulatory-authorities", "type": "clause", "offset": [162, 184]}, {"key": "regulatory-approvals", "type": "definition", "offset": [208, 228]}, {"key": "licensed-product", "type": "clause", "offset": [235, 251]}, {"key": "product-labeling", "type": "clause", "offset": [344, 360]}, {"key": "with-respect-to", "type": "clause", "offset": [387, 402]}], "samples": [{"hash": "8XQXSot3AyX", "uri": "/contracts/8XQXSot3AyX#clinical-studies", "label": "Exclusive License Agreement (Ablynx NV)", "score": 28.7508563995, "published": true}, {"hash": "hxGqSiI7F5T", "uri": "/contracts/hxGqSiI7F5T#clinical-studies", "label": "Exclusive License Agreement (Ablynx NV)", "score": 28.6605072021, "published": true}, {"hash": "7oTwcsEW75j", "uri": "/contracts/7oTwcsEW75j#clinical-studies", "label": "Exclusive License Agreement (Ablynx NV)", "score": 28.6057491302, "published": true}], "size": 22, "hash": "23a265469f8f63b2e8f816b348a1a3cd", "id": 3}, {"snippet": "means Phase 0, Phase I, Phase II, Phase III, and such other tests and studies in human subjects that are required by Applicable Law, or otherwise recommended by the Regulatory Authorities, to obtain or maintain Regulatory Approvals for a Licensed Product for one (1) or more Indications, including tests or studies that are intended to expand the Product Labeling for such Licensed Product with respect to such Indication.", "snippet_links": [{"key": "phase-0", "type": "definition", "offset": [6, 13]}, {"key": "phase-iii", "type": "definition", "offset": [34, 43]}, {"key": "tests-and-studies", "type": "clause", "offset": [60, 77]}, {"key": "in-human-subjects", "type": "clause", "offset": [78, 95]}, {"key": "required-by", "type": "definition", "offset": [105, 116]}, {"key": "applicable-law", "type": "definition", "offset": [117, 131]}, {"key": "regulatory-authorities", "type": "clause", "offset": [165, 187]}, {"key": "regulatory-approvals", "type": "definition", "offset": [211, 231]}, {"key": "licensed-product", "type": "clause", "offset": [238, 254]}, {"key": "product-labeling", "type": "clause", "offset": [347, 363]}, {"key": "with-respect-to", "type": "clause", "offset": [390, 405]}], "samples": [{"hash": "iin8hiIQlX", "uri": "/contracts/iin8hiIQlX#clinical-studies", "label": "Co Development and License Agreement (CytomX Therapeutics, Inc.)", "score": 26.5872688293, "published": true}, {"hash": "2sL5mf496j6", "uri": "/contracts/2sL5mf496j6#clinical-studies", "label": "Discovery Collaboration and License Agreement (CytomX Therapeutics, Inc.)", "score": 26.5872688293, "published": true}, {"hash": "l95SP8oLElX", "uri": "https://ir.cytomx.com/static-files/c05191f7-624e-46eb-a247-75de85c0b7bc", "label": "ir.cytomx.com", "score": 9.8405199051, "published": false}], "size": 20, "hash": "23608b605a2958798d914122ac24ddf2", "id": 4}, {"snippet": "means human clinical trials for a Licensed Product and any other tests and studies for a Licensed Product in human subjects.", "snippet_links": [{"key": "human-clinical-trials", "type": "clause", "offset": [6, 27]}, {"key": "licensed-product", "type": "clause", "offset": [34, 50]}, {"key": "tests-and-studies", "type": "clause", "offset": [65, 82]}, {"key": "in-human-subjects", "type": "clause", "offset": [106, 123]}], "samples": [{"hash": "fTPKoTHFIML", "uri": "/contracts/fTPKoTHFIML#clinical-studies", "label": "License Agreement (Kardigan, Inc.)", "score": 37.3367556468, "published": true}, {"hash": "euHVHJx0G8s", "uri": "/contracts/euHVHJx0G8s#clinical-studies", "label": "License Agreement (Sionna Therapeutics, Inc.)", "score": 36.0444908142, "published": true}, {"hash": "dGGv09mJN09", "uri": "/contracts/dGGv09mJN09#clinical-studies", "label": "License Agreement (Sionna Therapeutics, Inc.)", "score": 35.9021224976, "published": true}], "size": 18, "hash": "971c518769365c6fb9ecc2d271b5b5b7", "id": 5}, {"snippet": "means all Clinical Phase I Studies, Clinical Phase II Studies and Clinical Phase III Studies, including pivotal studies.", "snippet_links": [{"key": "phase-i-studies", "type": "clause", "offset": [19, 34]}, {"key": "phase-ii-studies", "type": "definition", "offset": [45, 61]}, {"key": "phase-iii-studies", "type": "definition", "offset": [75, 92]}], "samples": [{"hash": "2DFEtAAqMa5", "uri": "/contracts/2DFEtAAqMa5#clinical-studies", "label": "Licence Agreement (CureVac N.V.)", "score": 36.274471283, "published": true}, {"hash": "j02KvuFtwed", "uri": "/contracts/j02KvuFtwed#clinical-studies", "label": "Covid Cla Third Amendment and Restatement Agreement (CureVac N.V.)", "score": 33.3203277588, "published": true}, {"hash": "fyU9yu51jLI", "uri": "/contracts/fyU9yu51jLI#clinical-studies", "label": "Fourth Amendment and Restatement Agreement (CureVac N.V.)", "score": 33.3203277588, "published": true}], "size": 16, "hash": "2bfbbfcbae50c2232d122a6b1866e3ac", "id": 6}, {"snippet": "means any study in which human subjects are dosed with a drug, whether approved or investigational, including any Phase 1, 2, 3 or 4 study.", "snippet_links": [{"key": "human-subjects", "type": "definition", "offset": [25, 39]}, {"key": "phase-1", "type": "definition", "offset": [114, 121]}], "samples": [{"hash": "821lG3PlG5w", "uri": "/contracts/821lG3PlG5w#clinical-studies", "label": "License Agreement (Selecta Biosciences Inc)", "score": 28.6084880829, "published": true}, {"hash": "bHhW9I7gpP7", "uri": "/contracts/bHhW9I7gpP7#clinical-studies", "label": "License Agreement (Selecta Biosciences Inc)", "score": 27.3928813934, "published": true}, {"hash": "5vkPvoEKPzY", "uri": "/contracts/5vkPvoEKPzY#clinical-studies", "label": "License Agreement (Selecta Biosciences Inc)", "score": 27.2094459534, "published": true}], "size": 9, "hash": "3adaf54666780eae35c4a9fdeb07e790", "id": 7}, {"snippet": "means research studies in humans that are (a) designed in accordance with international ethical and scientific quality standards for designing, conducting, recording, and reporting research studies involving investigational medicinal products for human use and that involve the participation of human subjects, which standards are established through applicable Laws, and (b) designed to generate clinical data and results regarding a biological molecule in support of Marketing Approval, including any translational research studies. Clinical Studies include, but are not limited to, any \u2587\u2587\u2587\u2587\u2587 \u2587 Clinical Study, Phase 2 Clinical Study, or Pivotal Clinical Study.", "snippet_links": [{"key": "research-studies", "type": "clause", "offset": [6, 22]}, {"key": "in-accordance-with", "type": "definition", "offset": [55, 73]}, {"key": "quality-standards", "type": "clause", "offset": [111, 128]}, {"key": "investigational-medicinal-products", "type": "clause", "offset": [208, 242]}, {"key": "human-use", "type": "definition", "offset": [247, 256]}, {"key": "the-participation", "type": "clause", "offset": [274, 291]}, {"key": "human-subjects", "type": "definition", "offset": [295, 309]}, {"key": "applicable-laws", "type": "definition", "offset": [351, 366]}, {"key": "to-generate", "type": "definition", "offset": [385, 396]}, {"key": "clinical-data-and-results", "type": "definition", "offset": [397, 422]}, {"key": "marketing-approval", "type": "definition", "offset": [469, 487]}, {"key": "not-limited", "type": "clause", "offset": [569, 580]}, {"key": "phase-2-clinical-study", "type": "definition", "offset": [613, 635]}, {"key": "pivotal-clinical-study", "type": "clause", "offset": [640, 662]}], "samples": [{"hash": "eZw8VhlZ7Ch", "uri": "/contracts/eZw8VhlZ7Ch#clinical-studies", "label": "License and Collaboration Agreement (Pieris Pharmaceuticals, Inc.)", "score": 29.5776863098, "published": true}, {"hash": "6bj6HbxlZcQ", "uri": "/contracts/6bj6HbxlZcQ#clinical-studies", "label": "Non Exclusive Anticalin Platform Technology License Agreement (Pieris Pharmaceuticals, Inc.)", "score": 29.353181839, "published": true}, {"hash": "1F7NiN3Blxq", "uri": "/contracts/1F7NiN3Blxq#clinical-studies", "label": "License and Collaboration Agreement (Pieris Pharmaceuticals, Inc.)", "score": 29.353181839, "published": true}], "size": 8, "hash": "3330b6727182851ccc24b1ac6fd51840", "id": 8}, {"snippet": "means collectively any Phase I Clinical Studies, Phase II Clinical Studies, Phase III Clinical Studies and Phase IV/Post-Approval Clinical Studies, and any other study in which human subjects are dosed with a drug, whether approved or investigational, in each case of a Licensed Product within the Field.", "snippet_links": [{"key": "phase-i-clinical-studies", "type": "definition", "offset": [23, 47]}, {"key": "phase-ii-clinical-studies", "type": "definition", "offset": [49, 74]}, {"key": "phase-iii-clinical-studies", "type": "definition", "offset": [76, 102]}, {"key": "phase-iv", "type": "clause", "offset": [107, 115]}, {"key": "other-study", "type": "clause", "offset": [156, 167]}, {"key": "human-subjects", "type": "definition", "offset": [177, 191]}, {"key": "each-case", "type": "definition", "offset": [255, 264]}, {"key": "licensed-product", "type": "clause", "offset": [270, 286]}, {"key": "the-field", "type": "definition", "offset": [294, 303]}], "samples": [{"hash": "1xdwL8WDc7v", "uri": "/contracts/1xdwL8WDc7v#clinical-studies", "label": "Collaboration and License Agreement (Alector, Inc.)", "score": 31.5865840912, "published": true}, {"hash": "1xS6eojFwoT", "uri": "https://investors.alector.com/static-files/2a83d3d6-b323-44b7-a966-547d82e3af26", "label": "investors.alector.com", "score": 10.7932920456, "published": false}], "size": 7, "hash": "9ad443d66acee4336326fe0fa9029dbf", "id": 9}, {"snippet": "means Phase I Clinical Studies, Phase II Clinical Studies, Phase III Clinical Studies, and/or Post-Registration Studies.", "snippet_links": [{"key": "phase-i-clinical-studies", "type": "definition", "offset": [6, 30]}, {"key": "phase-ii-clinical-studies", "type": "definition", "offset": [32, 57]}, {"key": "phase-iii-clinical-studies", "type": "definition", "offset": [59, 85]}], "samples": [{"hash": "eBrPTQpFg8M", "uri": "/contracts/eBrPTQpFg8M#clinical-studies", "label": "Option and License Agreement (Furiex Pharmaceuticals, Inc.)", "score": 21.3942508698, "published": true}, {"hash": "jFZUTcPFKEw", "uri": "/contracts/jFZUTcPFKEw#clinical-studies", "label": "Option and License Agreement (Furiex Pharmaceuticals, Inc.)", "score": 21.3641338348, "published": true}, {"hash": "3re0f4a7KDY", "uri": "/contracts/3re0f4a7KDY#clinical-studies", "label": "Option and License Agreement (Furiex Pharmaceuticals, Inc.)", "score": 21.1478443146, "published": true}], "size": 6, "hash": "ab9187eaec495952f31eefbd59f58f83", "id": 10}], "next_curs": "Cl0SV2oVc35sYXdpbnNpZGVyY29udHJhY3RzcjkLEhpEZWZpbml0aW9uU25pcHBldEdyb3VwX3Y1NiIZY2xpbmljYWwtc3R1ZGllcyMwMDAwMDAwYQyiAQJlbhgAIAA=", "definition": {"snippet": "means a Phase \u2587 \u2587\u2587\u2587\u2587\u2587, \u2587\u2587\u2587\u2587\u2587 \u2587 \u2587\u2587\u2587\u2587\u2587, \u2587\u2587\u2587\u2587\u2587 \u2587 Trial or Phase 4 Trial, or such other study in humans that is conducted in accordance with good clinical practices and is designed to generate data in support or maintenance of an NDA, MAA or other similar marketing application.", "title": "Clinical Studies", "size": 348, "id": "clinical-studies", "examples": ["LICENSOR and LICENSEE shall jointly determine personnel, including without limitation investigators, principal investigators, study coordinators, research pharmacists, study physicians (\u201cClinical Study Personnel\u201d) and sites for the conduct of <strong>Clinical Studies</strong> for the LICENSED PRODUCT within the Licensed Field.", "LICENSEE shall bear all costs and expenses reasonably incurred by LICENSOR in performance of the R&amp;D Work (\u201cR&amp;D Costs\u201d), including, but not limited to personnel costs, costs of purchasing research equipment, materials, clinical trial consultations, pre-review costs, and <strong>Clinical Studies</strong>.", "LICENSOR hereby agrees to use commercially reasonable efforts to conduct any and all research and development activities, including without limitation <strong>Clinical Studies</strong> (\u201cR&amp;D Work\u201d) reasonably necessary to develop Licensed Product within the Territory for use within the Licensed Field, including, without limitation, to obtain Market Approval."], "related": [["clinical-study", "Clinical Study", "Clinical Study"], ["clinical-trials", "Clinical Trials", "Clinical Trials"], ["clinical-trial", "Clinical Trial", "Clinical Trial"], ["phase-i-clinical-study", "Phase I Clinical Study", "Phase I Clinical Study"], ["clinical", "Clinical", "Clinical"]], "related_snippets": [], "updated": "2026-05-28T05:54:56+00:00"}, "json": true, "cursor": ""}}